gynaecology regimens - comment on existing regimen Please complete this form and submit your comments or amendments Your Details: Your Name: Your Email:   Regimen Details: Gynaecology Regimen: Choose One BEP (3 day) ( v1.0 - Gynaecology - Germ cell tumours - 1st line) BEP (5 day) ( v1.0 - Gynaecology - Granulosa cell tumours) Carboplatin ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Carboplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma - 1st line) Carboplatin ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Carboplatin ( v1.0 - Gynaecology - Small cell cancers - Adjuvant) Carboplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Carboplatin ( v1.0 - Gynaecology - Small cell cancers - Palliative) Carboplatin ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Carboplatin - weekly ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Carboplatin - weekly ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Carboplatin - weekly ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Carboplatin - weekly ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma - 1st line) Carboplatin - weekly ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Carboplatin / Doxorubicin ( v1.0 - Gynaecology - Endometrial Cancer - Adjuvant) Carboplatin / Doxorubicin ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Carboplatin / Doxorubicin ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Carboplatin / Doxorubicin (as part of doublet) ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Carboplatin / Doxorubicin (as part of doublet) ( v1.0 - Gynaecology - Carcinosarcoma - Adjuvant) Carboplatin / Etoposide ( v1.0 - Gynaecology - Small cell cancers - Adjuvant) Carboplatin / Etoposide ( v1.0 - Gynaecology - Small cell cancers - Palliative) Carboplatin / Gemcitabine ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) CAV ( v1.0 - Gynaecology - Small cell cancers - Adjuvant) CAV ( v1.0 - Gynaecology - Small cell cancers - Palliative) Cisplatin ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Cisplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma - 1st line) Cisplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Cisplatin / Doxorubicin ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Cisplatin / Doxorubicin ( v1.0 - Gynaecology - Endometrial Cancer - Adjuvant) Cisplatin / Doxorubicin ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Cisplatin / Etoposide ( v1.0 - Gynaecology - Small cell cancers - Adjuvant) Cisplatin / Etoposide ( v1.0 - Gynaecology - Small cell cancers - Palliative) Cisplatin / Etoposide de Wit ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Cisplatin / Topotecan ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Cisplatin with concurrent XRT ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Docetaxel / Carboplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma - 1st line) Docetaxel / Carboplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Doxorubicin ( v1.0 - Gynaecology - Uterine Leiomyosarcoma - 1st line) Etoposide de Wit - Maintenance ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Ifosfamide ( v1.0 - Gynaecology - Uterine Leiomyosarcoma - 2nd line) Liposomal Doxorubicin (Caelyx) ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Oral Etoposide ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Paclitaxel ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Paclitaxel ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Paclitaxel ( v1.0 - Gynaecology - Cervical Cancer - 2nd line) Paclitaxel ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Paclitaxel ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Paclitaxel - weekly ( v1.0 - Gynaecology - Cervical Cancer - 2nd line) Paclitaxel - weekly ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Paclitaxel - weekly ( v1.0 - Gynaecology - Granulosa cell tumours) Paclitaxel - weekly ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Paclitaxel - weekly ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Paclitaxel - weekly ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Paclitaxel / Carboplatin ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Paclitaxel / Carboplatin ( v1.0 - Gynaecology - Endometrial Cancer - Adjuvant) Paclitaxel / Carboplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma - 1st line) Paclitaxel / Carboplatin ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Paclitaxel / Carboplatin ( v1.0 - Gynaecology - Cervical Cancer - 2nd line) Paclitaxel / Carboplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Paclitaxel / Carboplatin ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Paclitaxel / Carboplatin - dose dense weekly ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Paclitaxel / Carboplatin - dose dense weekly ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Paclitaxel / Carboplatin - dose dense weekly ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Paclitaxel / Carboplatin - dose dense weekly ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Paclitaxel / Carboplatin - weekly ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Paclitaxel / Carboplatin - weekly ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma - 1st line) Paclitaxel / Carboplatin - weekly ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Paclitaxel / Carboplatin - weekly ( v1.0 - Gynaecology - Cervical Cancer - 2nd line) Paclitaxel / Carboplatin - weekly ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Paclitaxel / Carboplatin - weekly ( v1.0 - Gynaecology - Endometrial Cancer - Palliative) Paclitaxel / Carboplatin (as part of doublet) ( v1.0 - Gynaecology - Carcinosarcoma - Adjuvant) Paclitaxel / Carboplatin (as part of doublet) ( v1.0 - Gynaecology - Carcinosarcoma - Palliative) Paclitaxel / Cisplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Paclitaxel / Cisplatin ( v1.0 - Gynaecology - Endometrial Cancer - Adjuvant) Paclitaxel / Cisplatin ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma - 1st line) TIP ( v1.0 - Gynaecology - Germ cell tumours - 2nd line) Topotecan ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Topotecan ( v1.0 - Gynaecology - Cervical Cancer - 2nd line) Topotecan ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Topotecan - weekly ( v1.0 - Gynaecology - Epithelial Ovarian Carcinoma -2nd and subsequent line) Topotecan - weekly ( v1.0 - Gynaecology - Cervical Cancer - 1st line) Topotecan - weekly ( v1.0 - Gynaecology - Cervical Cancer - 2nd line) Comments:

	Chemotherapy
	Adult regimens
	Gynaecology regimens